We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Experiences from a self-monitoring of blood glucose (SMBG) program in western Kenya
An evaluation questionnaire was based on the measures in the WHO policy on TB infection control in healthcare facilities
A meta-analysis of randomized controlled trials
Prospective cohort study
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
Diabetes mellitus triples the risk of TB and increases the probability of adverse TB treatment outcomes
A retrospective cohort study involving a review of records maintained under the National Diabetes Control Programme
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
Sets out the government's quality standards for diabetes services.
An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.
This article identifies some of the major programmatic management challenges
This study aims to identify the reasons for not undergoing confirmation by those at high risk for developing diabetes
A cluster randomised trial in Pakistan
A study was performed among the type 2 diabetes patients attending M.V. Hospital for Diabetes in Chennai
How to optimise the NHS Diabetes Prevention Programme in order to identify those at risk of Type 2 diabetes and help lower their risk of developing the disease.
How to use a cost effectiveness analysis to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.